메뉴 건너뛰기




Volumn 10, Issue 11, 2015, Pages

Merging children's oncology group data with an external administrative database using indirect patient identifiers: A report from the children's oncology group

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ALGORITHM; ARTICLE; CANCER MORTALITY; CHILDHOOD CANCER; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA BASE; HUMAN; HUMAN CELL; INFORMED CONSENT; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MEDICAL INFORMATION SYSTEM; MEDICAL SOCIETY; ONCOLOGY; ACUTE MYELOID LEUKEMIA; FACTUAL DATABASE; INFORMATION RETRIEVAL; PEDIATRICS; PHASE 3 CLINICAL TRIAL (TOPIC); REPRODUCIBILITY;

EID: 84960077417     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143480     Document Type: Article
Times cited : (16)

References (18)
  • 2
    • 23244459328 scopus 로고    scopus 로고
    • Criterion validity of medicare chemotherapy claims in cancer and leukemia group b breast and lung cancer trial participants
    • PMID: 16030306
    • Lamont EB1, Herndon JE 2nd, Weeks JC, Henderson IC, Lilenbaum R, Schilsky RL, et al. Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants. J Natl Cancer Inst. 2005; 97(14): 1080-1083. PMID: 16030306
    • (2005) J Natl Cancer Inst. , vol.97 , Issue.14 , pp. 1080-1083
    • Lamont, E.B.L.1    Herndon, I.I.J.E.2    Weeks, J.C.3    Henderson, I.C.4    Lilenbaum, R.5    Schilsky, R.L.6
  • 3
    • 33749030689 scopus 로고    scopus 로고
    • Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344
    • Cancer and Leukemia Group B PMID: 16985253
    • Lamont EB, Herndon JE 2nd, Weeks JC, Henderson IC, Earle CC, Schilsky RL, et al; Cancer and Leukemia Group B. Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst. 2006; 98(18): 1335-1338. PMID: 16985253
    • (2006) J Natl Cancer Inst. , vol.98 , Issue.18 , pp. 1335-1338
    • Lamont, E.B.1    Herndon, J.E.2    Weeks, J.C.3    Henderson, I.C.4    Earle, C.C.5    Schilsky, R.L.6
  • 4
    • 42449116613 scopus 로고    scopus 로고
    • Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants
    • Cancer and Leukemia Group B PMID: 18388845
    • Lamont EB, Herndon JE 2nd, Weeks JC, Henderson IC, Lilenbaum R, Schilsky RL, et al; Cancer and Leukemia Group B. Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants. Med Care. 2008; 46(3): 303-308. doi: 10.1097/MLR.0b013e31815cecc3 PMID: 18388845
    • (2008) Med Care. , vol.46 , Issue.3 , pp. 303-308
    • Lamont, E.B.1    Herndon, I.I.J.E.2    Weeks, J.C.3    Henderson, I.C.4    Lilenbaum, R.5    Schilsky, R.L.6
  • 5
    • 84860549778 scopus 로고    scopus 로고
    • Merging of the national cancer institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness reasech; A report from the Cihldren's Oncology Group
    • Aplenc R, Fisher BT, Huang YS, Li Y, Alonzo TA, Gerbing RB, et al. Merging of the national cancer institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness reasech; a report from the Cihldren's Oncology Group. Pharmacoepidemiolo Drug Saf. 2012; 21(S2): 37-43.
    • (2012) Pharmacoepidemiolo Drug Saf. , vol.21 , Issue.S2 , pp. 37-43
    • Aplenc, R.1    Fisher, B.T.2    Huang, Y.S.3    Li, Y.4    Alonzo, T.A.5    Gerbing, R.B.6
  • 6
    • 84907192040 scopus 로고    scopus 로고
    • Gemtuzumab ozogamicin in children and adolescents with De novo acute myeloid leukemia improves event-free survival by reducing relapse risk: Results from the randomized phase III Children's Oncology Group trial AAML0531
    • Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, et al. Gemtuzumab ozogamicin in children and adolescents with De novo acute myeloid leukemia improves event-free survival by reducing relapse risk: Results from the randomized phase III Children's Oncology Group trial AAML0531. JCO. 2014
    • (2014) JCO.
    • Gamis, A.S.1    Alonzo, T.A.2    Meshinchi, S.3    Sung, L.4    Gerbing, R.B.5    Raimondi, S.C.6
  • 7
    • 70350560658 scopus 로고    scopus 로고
    • Cefepime and mortality in pediatric acute myelogenous leukemia: A retrospective cohort study
    • PMID: 19859014
    • Fisher BT, Aplenc R, Localio R, Leckerman KH, Zaoutis TE. Cefepime and mortality in pediatric acute myelogenous leukemia: A retrospective cohort study. Pediatr Infect Dis J. 2009; 28(11): 971-975. doi: 10.1097/INF.0b013e3181a75939 PMID: 19859014
    • (2009) Pediatr Infect Dis J. , vol.28 , Issue.11 , pp. 971-975
    • Fisher, B.T.1    Aplenc, R.2    Localio, R.3    Leckerman, K.H.4    Zaoutis, T.E.5
  • 8
    • 77957052786 scopus 로고    scopus 로고
    • Risk factors for renal failure in pediatric patients with acute myeloid leukemia: A retrospective cohort study
    • PMID: 20533519
    • Fisher BT, Zaoutis TE, Leckerman KH, Localio R, Aplenc R. Risk factors for renal failure in pediatric patients with acute myeloid leukemia: A retrospective cohort study. Pediatr Blood Cancer. 2010; 55(4): 655-661. doi: 10.1002/pbc.22601 PMID: 20533519
    • (2010) Pediatr Blood Cancer. , vol.55 , Issue.4 , pp. 655-661
    • Fisher, B.T.1    Zaoutis, T.E.2    Leckerman, K.H.3    Localio, R.4    Aplenc, R.5
  • 9
    • 84872437560 scopus 로고    scopus 로고
    • Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children's hospitals in the United States using an administrative database
    • PMID: 23192853
    • Kavcic M, Fisher BT, Torp K, Li Y, Huang YV, Seif AE, et al. Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children's hospitals in the United States using an administrative database. Pediatr Blood Cancer. 2013; 60(3): 508-511 doi: 10.1002/pbc.24402 PMID: 23192853
    • (2013) Pediatr Blood Cancer. , vol.60 , Issue.3 , pp. 508-511
    • Kavcic, M.1    Fisher, B.T.2    Torp, K.3    Li, Y.4    Huang, Y.V.5    Seif, A.E.6
  • 10
    • 84877584544 scopus 로고    scopus 로고
    • Induction mortality and resource utilization in children treated for ccute myeloid leukemia from 1999 to 2010 at 39 free-standing pediatric hospitals in the United States
    • PMID: 23436301
    • Kavcic M, Fisher BT, Li Y, Seif AE, Torp K, Walker D, et al. Induction mortality and resource utilization in children treated for ccute myeloid leukemia from 1999 to 2010 at 39 free-standing pediatric hospitals in the United States. Cancer. 2013; 119(10): 1916-1923. doi: 10.1002/cncr.27957 PMID: 23436301
    • (2013) Cancer. , vol.119 , Issue.10 , pp. 1916-1923
    • Kavcic, M.1    Fisher, B.T.2    Li, Y.3    Seif, A.E.4    Torp, K.5    Walker, D.6
  • 11
    • 84894095267 scopus 로고    scopus 로고
    • Outcome of pediatric acute myeloid leukemia patients receiving intensive care interventions in the United States
    • PMID: 24366507
    • Maude SL, Fitzgerald JC, Fisher BT, Li Y, Huang YV, Torp K, et al. Outcome of pediatric acute myeloid leukemia patients receiving intensive care interventions in the United States. Pediatr Crit Care Med. 2014; 15(2): 112-120, doi: 10.1097/PCC.0000000000000042 PMID: 24366507
    • (2014) Pediatr Crit Care Med. , vol.15 , Issue.2 , pp. 112-120
    • Maude, S.L.1    Fitzgerald, J.C.2    Fisher, B.T.3    Li, Y.4    Huang, Y.V.5    Torp, K.6
  • 12
    • 84893256401 scopus 로고    scopus 로고
    • Antifungal prophylaxis associated with decreased induction mortality rates and resource utilized in children with new onset acute myeloid leukemia
    • Fisher BT, Kavcic M, Li Y, Seif AE, Bagatell R, Huang YV, et al. Antifungal prophylaxis associated with decreased induction mortality rates and resource utilized in children with new onset acute myeloid leukemia. Clin Infec Dis. 2014; 58(4): 502-508.
    • (2014) Clin Infec Dis. , vol.58 , Issue.4 , pp. 502-508
    • Fisher, B.T.1    Kavcic, M.2    Li, Y.3    Seif, A.E.4    Bagatell, R.5    Huang, Y.V.6
  • 13
    • 84908545828 scopus 로고    scopus 로고
    • Predictors of antiemetic alteration in pediatric acute myeloid leukemia
    • PMID 24939039
    • Freedman JL, Faerber J, Kang TI, Dai D, Localio AR, Fisher BT, et al. Predictors of antiemetic alteration in pediatric acute myeloid leukemia. Pediatr Blood Cancer. 2014; 61(10):1798-1805 doi: 10.1002/pbc. 25108 PMID: 24939039
    • (2014) Pediatr Blood Cancer. , vol.61 , Issue.10 , pp. 1798-1805
    • Freedman, J.L.1    Faerber, J.2    Kang, T.I.3    Dai, D.4    Localio, A.R.5    Fisher, B.T.6
  • 14
    • 29244488576 scopus 로고    scopus 로고
    • Validiation of probabiistic linkage to match de-dentified ambulance records to a state trauma registry
    • PMID: 16365326
    • Neward CD. Validiation of probabiistic linkage to match de-dentified ambulance records to a state trauma registry. Acad Emerg Med. 2006; 13(1): 69-75. PMID: 16365326
    • (2006) Acad Emerg Med. , vol.13 , Issue.1 , pp. 69-75
    • Neward, C.D.1
  • 15
    • 34547575166 scopus 로고    scopus 로고
    • Probabilistic record linkage is a valid and transparent tool to combine databsess without a patient identification number
    • PMID: 17689804
    • Meray N, Beitsma JB, Ravelli ACK, Bonsel GJ. Probabilistic record linkage is a valid and transparent tool to combine databsess without a patient identification number. J Clin Epidemiol. 2007; 60(9): 883-891. PMID: 17689804
    • (2007) J Clin Epidemiol. , vol.60 , Issue.9 , pp. 883-891
    • Meray, N.1    Beitsma, J.B.2    Ravelli, A.C.K.3    Bonsel, G.J.4
  • 16
    • 67049159418 scopus 로고    scopus 로고
    • Linking inpatient clinical registry data to Medicare claims data using indirect identifiers
    • PMID: 19464409
    • Hammill BG, Hernandez AF, Peterson ED, Fonarow GC, Schulman KA, Curtis LH. Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J. 2009; 157(6): 995-1000. doi: 10.1016/j.ahj.2009.04.002 PMID: 19464409
    • (2009) Am Heart J. , vol.157 , Issue.6 , pp. 995-1000
    • Hammill, B.G.1    Hernandez, A.F.2    Peterson, E.D.3    Fonarow, G.C.4    Schulman, K.A.5    Curtis, L.H.6
  • 17
    • 78650153256 scopus 로고    scopus 로고
    • Linking clinical registry data with administrative data using indirect identifiers: Implementation and validation in the congenital heaert surgery population
    • PMID: 21146664
    • Pasquali SK, Jocobs JP, Shook GJ, Obrien SM, Hall M, Jacobs ML, et al. Linking clinical registry data with administrative data using indirect identifiers: ImPlEmEnTaTiOn aNd vAlIdAtIoN In tHe cOnGeNiTaL HeAeRt sUrGeRy pOpUlAtIoN. AM Heart J. 2010; 160(6): 1099-1104. doi: 10.1016/j.ahj.2010.08.010 PMID: 21146664
    • (2010) Am Heart J. , vol.160 , Issue.6 , pp. 1099-1104
    • Pasquali, S.K.1    Jocobs, J.P.2    Shook, G.J.3    Obrien, S.M.4    Hall, M.5    Jacobs, M.L.6
  • 18
    • 84873990001 scopus 로고    scopus 로고
    • Linkage of a clinical surgical regisry with Medicare inpatient claims data using indirect identifiers
    • PMID: 23122901
    • Lawson EH, Ko CY, Louie R, Han L, Rapp M, Zingmond DS. Linkage of a clinical surgical regisry with Medicare inpatient claims data using indirect identifiers. Surgery. 2012; 153(3): 423-430. doi: 10.1016/j.surg.2012.08.065 PMID: 23122901
    • (2012) Surgery. , vol.153 , Issue.3 , pp. 423-430
    • Lawson, E.H.1    Ko, C.Y.2    Louie, R.3    Han, L.4    Rapp, M.5    Zingmond, D.S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.